Obesity Pathway Innovation Programme
Supports health systems in the United Kingdom to pilot coordinated obesity care pathways through integrated prevention and treatment services.
About
OPIP Strand 3 is a £85M co-funded programme (DSIT £50M, Eli Lilly £35M) for NHS bodies to pilot integrated obesity care pathways combining an access/management service with a care pathway service. Eligible lead applicants are NHS Integrated Care Boards (England), Health Boards (Scotland), local health boards (Wales), and HSC trusts (Northern Ireland). Total eligible costs per project: £2–8M; 100% …
MedtechBiotech
Max award£8M
Realistic median—
Success rate—
Decision time—
No upcoming rounds verified. Cadence: One-off.